Accessibility settings

Published on in Vol 9 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/45747, first published .
Doctor in glasses and lab coat discusses patient chart in medical office

Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study

Journals

  1. Huang K. The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies. JMIR Public Health and Surveillance 2024;10:e51372 View
  2. Wang L, Liu S, Jiang S, Li C, Lu L, Fang Y, Li S. Authors’ Reply: “The Need for a Bleed Type–Specific Annual Bleeding Rate in Hemophilia Studies”. JMIR Public Health and Surveillance 2024;10:e54756 View
  3. Nouwens S, Marceta S, Bui M, van Dijk D, Groothuis-Oudshoorn C, Veldwijk J, van Til J, de Bekker-Grob E. The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review. PharmacoEconomics 2025;43(8):879 View
  4. Cheng H, Jiang S, Liu T, Li B, Chen S, Li A, Chen H, Wang H, Gu Y. How policymakers value end-of-life treatments for rare and common diseases in China: evidence from a contingent valuation study. Global Health Research and Policy 2025;10(1) View
  5. Yuan J, Li S, Dou L, Xing H, Lu L, Jiang S. Treatment Preferences in Adult Patients with Type 2 and Type 3 Spinal Muscular Atrophy: Evidence from a Discrete Choice Experiment in China. The Patient - Patient-Centered Outcomes Research 2026 View
  6. Yao Z, Zhang Y, Shu J, Ying T, Li J, Xu Y, Zhu Q, Xu R, Zhang Y, Xie X. Physician preferences for prescribing Chinese patent medicines during pregnancy: a discrete choice experiment. Frontiers in Pharmacology 2026;17 View